CoChat
Sign Up
Cited by 53

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

A cell-autonomous role for border-associated macrophages in ApoE4 neurovascular dysfunction and susceptibility to white matter injury

Anfray, Antoine, Schaeffer, Samantha, Hattori, Yorito, Santisteban, Monica M., Casey, Nicole, Wang, Gang, Strickland, Michael, Zhou, Ping, Holtzman, David M., Anrather, Josef, Park, Laibaik, Iadecola, Costantino·2024·Nature Neuroscience
DOI 10.1038/s41593-024-01757-6PMC PMC11758676

Published version of a preprint

Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41593-024-01757-6

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 29 references

Research works printed but not linked: 70

  1. Iadecola, C. et al. The neurovasculome: key roles in brain health and cognitive impairment: a scientific statement from the American Heart Association/American Stroke Association. Stroke 54, e251–e271 (2023). · DOI
  2. Iadecola, C. et al. Vascular cognitive impairment and dementia: JACC Scientific Expert Panel. J. Am. Coll. Cardiol. 73, 3326–3344 (2019). · DOI
  3. Vemuri, P. et al. White matter abnormalities are key components of cerebrovascular disease impacting cognitive decline. Brain Commun. 3, fcab076 (2021). · DOI
  4. Festa, L. K., Grinspan, J. B. & Jordan-Sciutto, K. L. White matter injury across neurodegenerative disease. Trends Neurosci. 47, 47–57 (2024). · DOI
  5. McAleese, K. E. et al. Frontal white matter lesions in Alzheimer’s disease are associated with both small vessel disease and AD-associated cortical pathology. Acta Neuropathol. 142, 937–950 (2021). · DOI
  6. Phuah, C. L. et al. Association of data-driven white matter hyperintensity spatial signatures with distinct cerebral small vessel disease etiologies. Neurology 99, e2535–e2547 (2022). · DOI
  7. Soldan, A. et al. White matter hyperintensities and CSF Alzheimer disease biomarkers in preclinical Alzheimer disease. Neurology 94, e950–e960 (2020). · DOI
  8. Feekes, J. A., Hsu, S. W., Chaloupka, J. C. & Cassell, M. D. Tertiary microvascular territories define lacunar infarcts in the basal ganglia. Ann. Neurol. 58, 18–30 (2005). · DOI · Paper page
  9. Vogels, V., Dammers, R., van Bilsen, M. & Volovici, V. Deep cerebral perforators: anatomical distribution and clinical symptoms: an overview. Stroke 52, e660–e674 (2021). · DOI
  10. Horsburgh, K. et al. Small vessels, dementia and chronic diseases—molecular mechanisms and pathophysiology. Clin. Sci. 132, 851–868 (2018). · DOI
  11. Wardlaw, J. M., Smith, C. & Dichgans, M. Small vessel disease: mechanisms and clinical implications. Lancet Neurol. 18, 684–696 (2019). · DOI · Paper page
  12. Bordes, C., Sargurupremraj, M., Mishra, A. & Debette, S. Genetics of common cerebral small vessel disease. Nat. Rev. Neurol. 18, 84–101 (2022). · DOI
  13. El Husseini, N. et al. Cognitive impairment after ischemic and hemorrhagic stroke: a scientific statement from the American Heart Association/American Stroke Association. Stroke 54, e272–e291 (2023). · DOI · Paper page
  14. Pendlebury, S. T. et al. APOE-epsilon4 genotype and dementia before and after transient ischemic attack and stroke: population-based cohort study. Stroke 51, 751–758 (2020). · DOI
  15. Grinberg, L. T. & Thal, D. R. Vascular pathology in the aged human brain. Acta Neuropathol. 119, 277–290 (2010). · DOI · Paper page
  16. Lamar, M. et al. APOE genotypes as a risk factor for age-dependent accumulation of cerebrovascular disease in older adults. Alzheimer’s Dement. 15, 258–266 (2019). · DOI · Paper page
  17. Pinheiro, A. et al. Association of apolipoprotein E varepsilon4 allele with enlarged perivascular spaces. Ann. Neurol. 92, 23–31 (2022). · DOI
  18. Rojas, S. et al. Higher prevalence of cerebral white matter hyperintensities in homozygous APOE-varepsilon4 allele carriers aged 45–75: results from the ALFA study. J. Cereb. Blood Flow Metab. 38, 250–261 (2018). · DOI
  19. Sudre, C. H. et al. APOE epsilon4 status is associated with white matter hyperintensities volume accumulation rate independent of AD diagnosis. Neurobiol. Aging 53, 67–75 (2017). · DOI
  20. Salloway, S. et al. Amyloid-related imaging abnormalities in 2 phase 3 studies evaluating aducanumab in patients with early Alzheimer disease. JAMA Neurol. 79, 13–21 (2022). · DOI · Paper page
  21. Sperling, R. A. et al. Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging–Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s Dement. 7, 280–292 (2011). · DOI · Paper page
  22. van Dyck, C. H. et al. Lecanemab in early Alzheimer’s disease. N. Engl. J. Med. 388, 9–21 (2023). · DOI · Paper page
  23. Castellani, R. J. et al. Neuropathology of anti-amyloid-beta immunotherapy: a case report. J. Alzheimers Dis. 93, 803–813 (2023). · DOI
  24. Solopova, E. et al. Fatal iatrogenic cerebral beta-amyloid-related arteritis in a woman treated with lecanemab for Alzheimer’s disease. Nat. Commun. 14, 8220 (2023). · DOI
  25. Hays, C. C. et al. APOE modifies the interaction of entorhinal cerebral blood flow and cortical thickness on memory function in cognitively normal older adults. Neuroimage 202, 116162 (2019). · DOI
  26. Thambisetty, M., Beason-Held, L., An, Y., Kraut, M. A. & Resnick, S. M. APOE epsilon4 genotype and longitudinal changes in cerebral blood flow in normal aging. Arch. Neurol. 67, 93–98 (2010). · DOI
  27. Koizumi, K. et al. Apoepsilon4 disrupts neurovascular regulation and undermines white matter integrity and cognitive function. Nat. Commun. 9, 3816 (2018). · DOI · Paper page
  28. Schaeffer, S. & Iadecola, C. Revisiting the neurovascular unit. Nat. Neurosci. 24, 1198–1209 (2021). · DOI
  29. Masuda, T., Amann, L. & Prinz, M. Novel insights into the origin and development of CNS macrophage subsets. Clin. Transl. Med. 12, e1096 (2022). · DOI
  30. Prinz, M., Masuda, T., Wheeler, M. A. & Quintana, F. J. Microglia and central nervous system-associated macrophages—from origin to disease modulation. Annu. Rev. Immunol. 39, 251–277 (2021). · DOI · Paper page
  31. Lin, X. et al. Perivascular macrophages mediate microvasospasms after experimental subarachnoid hemorrhage. Stroke 54, 2126–2134 (2023). · DOI
  32. Santisteban, M. M. et al. Endothelium-macrophage crosstalk mediates blood–brain barrier dysfunction in hypertension. Hypertension 76, 795–807 (2020). · DOI
  33. Levard, D. et al. Central nervous system-associated macrophages modulate the immune response following stroke in aged mice. Nat. Neurosci. https://doi.org/10.1038/s41593-024-01695-3 (2024). · DOI
  34. Park, L. et al. Tau induces PSD95-neuronal NOS uncoupling and neurovascular dysfunction independent of neurodegeneration. Nat. Neurosci. 23, 1079–1089 (2020). · DOI
  35. Toda, N., Ayajiki, K. & Okamura, T. Cerebral blood flow regulation by nitric oxide: recent advances. Pharmacol. Rev. 61, 62–97 (2009). · DOI
  36. Chen, Y., Strickland, M. R., Soranno, A. & Holtzman, D. M. Apolipoprotein E: structural insights and links to Alzheimer disease pathogenesis. Neuron 109, 205–221 (2021). · DOI · Paper page
  37. Bu, G. Receptor-associated protein: a specialized chaperone and antagonist for members of the LDL receptor gene family. Curr. Opin. Lipidol. 9, 149–155 (1998). · DOI
  38. Kazama, K. et al. Angiotensin II impairs neurovascular coupling in neocortex through NADPH oxidase-derived radicals. Circ. Res. 95, 1019–1026 (2004). · DOI · Paper page
  39. Knock, G. A. NADPH oxidase in the vasculature: expression, regulation and signalling pathways; role in normal cardiovascular physiology and its dysregulation in hypertension. Free Radic. Biol. Med. 145, 385–427 (2019). · DOI
  40. Wang, G. et al. Nox2, Ca2+, and protein kinase C play a role in angiotensin II-induced free radical production in nucleus tractus solitarius. Hypertension 48, 482–489 (2006). · DOI
  41. Park, L., Anrather, J., Girouard, H., Zhou, P. & Iadecola, C. Nox2-derived reactive oxygen species mediate neurovascular dysregulation in the aging mouse brain. J. Cereb. Blood Flow Metab. 27, 1908–1918 (2007). · DOI · Paper page
  42. Alata, W., Ye, Y., St-Amour, I., Vandal, M. & Calon, F. Human apolipoprotein E varepsilon4 expression impairs cerebral vascularization and blood-brain barrier function in mice. J. Cereb. Blood Flow Metab. 35, 86–94 (2015). · DOI
  43. Jackson, R. J. et al. APOE4 derived from astrocytes leads to blood-brain barrier impairment. Brain 145, 3582–3593 (2022). · DOI · Paper page
  44. Main, B. S. et al. Apolipoprotein E4 impairs spontaneous blood brain barrier repair following traumatic brain injury. Mol. Neurodegen. 13, 17 (2018). · DOI
  45. Santisteban, M. M. et al. Meningeal interleukin-17-producing T cells mediate cognitive impairment in a mouse model of salt-sensitive hypertension. Nat. Neurosci. 27, 63–77 (2024). · DOI
  46. Kockx, M. M. et al. Phagocytosis and macrophage activation associated with hemorrhagic microvessels in human atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 23, 440–446 (2003). · DOI
  47. Utter, S. et al. Cerebral small vessel disease-induced apolipoprotein E leakage is associated with Alzheimer disease and the accumulation of amyloid beta-protein in perivascular astrocytes. J. Neuropathol. Exp. Neurol. 67, 842–856 (2008). · DOI
  48. Lambertsen, K. L. et al. Differences in origin of reactive microglia in bone marrow chimeric mouse and rat after transient global ischemia. J. Neuropathol. Exp. Neurol. 70, 481–494 (2011). · DOI
  49. Shemer, A. et al. Engrafted parenchymal brain macrophages differ from microglia in transcriptome, chromatin landscape and response to challenge. Nat. Commun. 9, 5206 (2018). · DOI · Paper page
  50. Ajami, B., Bennett, J. L., Krieger, C., McNagny, K. M. & Rossi, F. M. Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool. Nat. Neurosci. 14, 1142–1149 (2011). · DOI · Paper page
  51. Diserbo, M. et al. Blood-brain barrier permeability after gamma whole-body irradiation: an in vivo microdialysis study. Can. J. Physiol. Pharmacol. 80, 670–678 (2002). · DOI
  52. Herz, J. Apolipoprotein E receptors in the nervous system. Curr. Opin. Lipidol. 20, 190–196 (2009). · DOI · Paper page
  53. Zhao, N., Liu, C. C., Qiao, W. & Bu, G. Apolipoprotein E, receptors, and modulation of Alzheimer’s disease. Biol. Psychiatry 83, 347–357 (2018). · DOI · Paper page
  54. Koutsodendris, N. et al. Neuronal APOE4 removal protects against tau-mediated gliosis, neurodegeneration and myelin deficits. Nat. Aging 3, 275–296 (2023). · DOI · Paper page
  55. Liu, C. C. et al. Peripheral apoE4 enhances Alzheimer’s pathology and impairs cognition by compromising cerebrovascular function. Nat. Neurosci. 25, 1020–1033 (2022). · DOI · Paper page
  56. Yamazaki, Y. et al. Vascular ApoE4 impairs behavior by modulating gliovascular function. Neuron 109, 438–447 e436 (2021). · DOI · Paper page
  57. Ruiz, J. et al. The apoE isoform binding properties of the VLDL receptor reveal marked differences from LRP and the LDL receptor. J. Lipid Res. 46, 1721–1731 (2005). · DOI · Paper page
  58. Piedrahita, J. A., Zhang, S. H., Hagaman, J. R., Oliver, P. M. & Maeda, N. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc. Natl Acad. Sci. USA 89, 4471–4475 (1992). · DOI · Paper page
  59. Zheng, K. et al. Single-cell RNA-seq reveals the transcriptional landscape in ischemic stroke. J. Cereb. Blood Flow Metab. 42, 56–73 (2022). · DOI
  60. Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888–1902.e1821 (2019). · DOI · Paper page
  61. Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289–1296 (2019). · DOI · Paper page
  62. Verghese, P. B. et al. ApoE influences amyloid-beta (Abeta) clearance despite minimal apoE/Abeta association in physiological conditions. Proc. Natl Acad. Sci. USA 110, E1807–E1816 (2013). · DOI · Paper page
  63. Uekawa, K. et al. Obligatory role of EP1 receptors in the Increase in cerebral blood flow produced by hypercapnia in the mice. PLoS ONE 11, e0163329 (2016). · DOI
  64. Garcia-Bonilla, L. et al. Analysis of brain and blood single-cell transcriptomics in acute and subacute phases after experimental stroke. Nat. Immunol. 25, 357–370 (2024). · DOI
  65. Kawano, T. et al. Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity. Nat. Med. 12, 225–229 (2006). · DOI
  66. Park, L. et al. The key role of transient receptor potential melastatin-2 channels in amyloid-beta-induced neurovascular dysfunction. Nat. Commun. 5, 5318 (2014). · DOI
  67. Park, L. et al. tPA deficiency underlies neurovascular coupling dysfunction by amyloid-beta. J. Neurosci. 40, 8160–8173 (2020). · DOI
  68. Aggleton, J. P. & Pearce, J. M. Neural systems underlying episodic memory: insights from animal research. Philos. Trans. R. Soc. Lond. B Biol. Sci. 356, 1467–1482 (2001). · DOI
  69. Dellu, F., Contarino, A., Simon, H., Koob, G. F. & Gold, L. H. Genetic differences in response to novelty and spatial memory using a two-trial recognition task in mice. Neurobiol. Learn. Mem. 73, 31–48 (2000). · DOI · Paper page
  70. Vorhees, C. V. & Williams, M. T. Assessing spatial learning and memory in rodents. ILAR J. 55, 310–332 (2014). · DOI

Cited by

Sorted by citations

See all 53

Metadata

Authors
Anfray, A., Schaeffer, S., Hattori, Y., Santisteban, M. M., Casey, N., Wang, G., Strickland, M., Zhou, P., Holtzman, D. M., Anrather, J., Park, L., & Iadecola, C.
Venue
Nature Neuroscience
Publisher
Springer Science and Business Media LLC
Published
2024-09-18
Volume
27
Issue
11
Pages
2138-2151
ISSN
  • 1097-6256
  • 1546-1726
DOI
10.1038/s41593-024-01757-6
PMC
PMC11758676
Cited by
53
References
29
Language
en
Licence
Funders
  • U.S. Department of Health & Human Services | National Institutes of Health (R01-NS126467, K22-NS123507, R01-NS097805)
  • Feil Family Foundation
  • BrightFocus Foundation (A2022003F)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review